Adaptive Biotechnologies Corp (NASDAQ:ADPT) has a beta value of 1.48 and has seen 1.74 million shares traded in the last trading session. The company, currently
Adaptive Biotechnologies Corp (NASDAQ:ADPT) has a beta value of 1.48 and has seen 0.46 million shares traded in the recent trading session. The company, currently
In the last trading session, 1.44 million shares of the Adaptive Biotechnologies Corp (NASDAQ:ADPT) were traded, and its beta was 1.48. Most recently the company’s
In the last trading session, 1.1 million shares of the Adaptive Biotechnologies Corp (NASDAQ:ADPT) were traded, and its beta was 1.48. Most recently the company’s
Adaptive Biotechnologies Corp (NASDAQ:ADPT)’s traded shares stood at 0.62 million during the last session, with the company’s beta value hitting 1.48. At the close of
In the last trading session, 1.06 million Adaptive Biotechnologies Corp (NASDAQ:ADPT) shares changed hands as the company’s beta touched 1.48. With the company’s per share
In the last trading session, 1.7 million Adaptive Biotechnologies Corp (NASDAQ:ADPT) shares changed hands as the company’s beta touched 1.49. With the company’s per share
In last trading session, Adaptive Biotechnologies Corp (NASDAQ:ADPT) saw 0.66 million shares changing hands with its beta currently measuring 1.48. Company’s recent per share price
Adaptive Biotechnologies Corp (NASDAQ:ADPT) has a beta value of 1.42 and has seen 2.33 million shares traded in the last trading session. The company, currently
In the last trading session, 1.71 million shares of the Adaptive Biotechnologies Corp (NASDAQ:ADPT) were traded, and its beta was 1.44. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
